Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Oncolytics Biotech Inc > Profile

Oncolytics Biotech Inc (ONCY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Two Sigma Advisors

John Overdeck And David Siegel

 122,000 $206 -17% 0%
2.
Citadel Investment Group

Ken Griffin

 23,139 $39 -40% 0%
3.
Renaissance Technologies

Jim Simons

 12,585 $21 0%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1.
International Assets Investment Management, Llc
 120,776 $287,447 0.05%
2.
Ifp Advisors, Inc
 5,000 $12 0%
3.
Jnba Financial Advisors
 210 $0 0%
News See All
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?

Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 817 13F filings...

Keep Reading →

November 26th, 2020 - Hedge Funds News

Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It

To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading sentiment. At Insider...

Keep Reading →

September 17th, 2013 - News

Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses...

Keep Reading →

September 3rd, 2013 - News

Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?

Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?

If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past. While there are more than 8000 funds in operation at present, we at Insider Monkey look...

Keep Reading →

July 1st, 2013 - News

Should You Avoid GTx, Inc. (GTXI)?

Should You Avoid GTx, Inc. (GTXI)?

Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view. The number of bullish hedge fund bets stayed the same which is a slightly negative...

Keep Reading →

July 1st, 2013 - News

Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look

Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look

Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating. The fortunes of a biotechnology can turn on a dime based on numerous factors that can...

Keep Reading →

June 27th, 2013 - News

This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)

This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)

Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months. There were 7 hedge funds in our database...

Keep Reading →

June 25th, 2013 - News

Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple

Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world. According to studies, every year approximately 7.5 million...

Keep Reading →

June 19th, 2013 - News

Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?

Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?

In the eyes of most market participants, hedge funds are viewed as slow, outdated investment tools of the past. While there are greater than 8000 funds with their doors open at present, we choose to focus...

Keep Reading →

June 13th, 2013 - News

Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential

Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential

Big pharmaceutical players, known as Big Pharma, depend on patents to fend of generic threats to their blockbuster drugs. So when a patent expires, cheaper generic products flood the market. The sales...

Keep Reading →

June 6th, 2013 - News

Click here to See All News
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.